Clinical Trial: A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata

U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07733765) titled 'A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata' on July 24.

Brief Summary: The purpose of this clinical study is to learn about the safety and effects of the study medicine (called ritlecitinib) for the potential treatment of moderate alopecia areata (AA).

This study is seeking participants who are

* 12 years or older (if permitted by the local IRB/EC and local regulatory health authority)

* have AA with patchy hair loss. The current episode of hair loss has lasted for 6 months or longer but 10 years or less

* do...